Coherus Oncology Inc

NAS:CHRSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$1.01−4.29%LiveIn session · ≈ AED 3.69 · Market cap $155.27M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	92.1%	82.4%	66.8%	38.2%	56.0%	57.9%	—	—
Operating margin	32.9%	−80.8%	−121.7%	−79.0%	−41.8%	−425.7%	−425.7%	+0.0 pts
Net margin	27.8%	−87.9%	−138.2%	−92.5%	10.7%	−403.8%	398.4%	+802.2 pts
EBITDA margin	34.0%	−79.8%	−121.1%	−75.4%	22.8%	−403.6%	—	—
Return on equity	47.1%	−293.8%	212.3%	123.0%	−21.6%	−279.1%	275.4%	+554.5 pts
Return on assets	15.7%	−42.3%	−60.7%	−37.8%	6.4%	−65.9%	65.0%	+131.0 pts
Return on capital employed	22.5%	−51.3%	−75.1%	−68.2%	−67.5%	−154.2%	—	—
Debt / equity	1.5×	4.3×	−3.5×	−2.5×	−2.0×	0.7×	0.7×	+0.0%
Debt / assets	49.6%	61.7%	99.9%	76.4%	60.2%	15.6%	—	—
Interest coverage	7.4×	−11.5×	−7.9×	−5.0×	−4.1×	−19.9×	—	—
Current ratio	5.3×	3.6×	2.7×	1.4×	1.2×	1.5×	1.5×	+0.0%
Quick ratio	5.0×	3.4×	2.5×	1.2×	1.0×	1.4×	—	—
Cash ratio	3.7×	2.5×	0.5×	0.3×	0.4×	0.6×	0.6×	+0.0%
Asset turnover	0.6×	0.5×	0.4×	0.4×	0.6×	0.2×	—	—
Inventory turnover	0.9×	1.5×	1.8×	2.5×	1.7×	5.6×	—	—
Receivables turnover	3.0×	2.7×	1.9×	1.0×	2.2×	2.3×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.